NAMD released a statement requesting federal policymakers’ consideration of key statutory flexibilities for the Medicaid program as part of overall health care reform efforts. The statement articulates Medicaid’s successes in recent years, but also situates Medicaid as one payer among many within the wider health care system. It notes that current reform conversations envision a […]
NAMD submitted comments to CMS on the agency’s proposed rule that would impact eligibility and fair hearing processes in Medicaid. In general, the Association’s letter expresses concern that the rule does not recognize the variation in process and procedure that is appropriate among states in the fair hearing process. Read full letter.
Two new NAMD documents outline key Medicaid issues and operational considerations for policymakers should they move forward in evaluating proposals to repeal and replace the Affordable Care Act (ACA) and/or make structural changes to Medicaid. NAMD has not taken positions on proposals related to the ACA or structural changes to the Medicaid program. Rather, these […]
NAMD submitted comments to CMS on the final Medicaid covered outpatient drug rule. In the comments, NAMD calls attention to implementation timeline challenges posed by the rule and provides a suggested approach for handling line extension drugs. Read full letter.
NAMD issued a memo providing Medicaid Directors with an update on CMS scrutiny of state electronic asset verification programs for aged, blind, and disabled Medicaid beneficiaries. The memo also flags key resources available to assist states in implementing their asset verification programs. NAMD Memo AVP Resources 3-31-16
The National Association of Medicaid Directors submitted a letter to the Centers for Medicare and Medicaid Services Acting Administrator Slavitt. The letter acknowledges progress made to improve Medicaid and Exchange interactions and calls for additional steps to improve the beneficiary experience and efficiency of operations. Read the full letter here.